Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
GLIDAPA 3D 10/100/10
GLIDAPA 3D 10/100/10
COD not available
DIABETIC RANGE by GLIDAPA 3D 10/100/1000 SR

GLIDAPA 3D 10/100/1000 SR

INR 416.5 INR 595
You Save: INR 178.5 (30%)

Description

Product details

GLIDAPA 3D 10/100/1000 SR Dapaflozin 10, Sitagliptin 100 mg & Metformin SR 1000 mg Introduction GLIDAPA 3D 10/100/1000 SR is a comprehensive oral medication tailored for the treatment of Type 2 diabetes. This potent combination incorporates Dapagliflozin (10 mg), Sitagliptin (100 mg), and a higher dose of Metformin (1000 mg, sustained release), designed to effectively manage high blood sugar levels throughout the day. Mechanism of Action Dapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin facilitates the removal of excess glucose from the body via the urine, helping to reduce blood glucose levels and also supporting weight loss and cardiovascular health. Sitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin increases the levels of incretin hormones, which enhances the pancreatic response to high blood sugar after meals by increasing insulin production and decreasing glucagon secretion. Metformin SR (1000 mg): The higher dose of Metformin in this formulation works to decrease hepatic glucose production, improve insulin sensitivity, and reduce glucose absorption in the intestines. The sustained-release form minimizes gastrointestinal side effects and provides more stable blood sugar control. Benefits GLIDAPA 3D 10/100/1000 SR offers a potent therapeutic strategy by combining three drugs, each targeting a different aspect of diabetes management. This not only maximizes glucose control but also simplifies the treatment regimen, potentially enhancing patient compliance and reducing the risk of long-term complications. Dosage and Administration Dosage: The dosage should be tailored to the individual’s current health status, effectiveness of the treatment, and tolerability. Regular monitoring of blood glucose and adjustment of the dose may be necessary. Administration: It is recommended to take the medication once daily in the morning, with or without food. The tablet should be swallowed whole to ensure proper release of Metformin over time. Side Effects Common side effects may include urinary tract infections (due to Dapagliflozin), potential gastrointestinal disturbances such as nausea or diarrhea (common with Metformin), and a sore throat or nasopharyngitis associated with Sitagliptin. These side effects are generally mild and manageable. Conclusion GLIDAPA 3D 10/100/1000 SR is a highly effective option for managing Type 2 diabetes, offering a strategic blend of three medications to control blood sugar levels, improve metabolic health, and reduce the risk of diabetes-related complications. This enhanced formulation is suitable for patients requiring a robust approach to diabetes management, emphasizing the importance of ongoing collaboration with healthcare providers to tailor and optimize treatment. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order Now https://www.sterisonline.com/product/glidapa-3d-10-100-1000-sr-134216

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us